Cargando…
Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S
Major histocompatibility complex class II (MHCII)-restricted antigen priming of CD4(+) T cells is both involved in adaptive immune responses and the pathogenesis of autoimmune diseases. Degradation of invariant chain Ii, a protein that prevents premature peptide loading, is a prerequisite for nascen...
Autores principales: | Theron, Michel, Bentley, Darren, Nagel, Sandra, Manchester, Marianne, Gerg, Michael, Schindler, Thomas, Silva, Ana, Ecabert, Barbara, Teixeira, Priscila, Perret, Camille, Reis, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512459/ https://www.ncbi.nlm.nih.gov/pubmed/28769925 http://dx.doi.org/10.3389/fimmu.2017.00806 |
Ejemplares similares
-
Population pharmacokinetic analysis of RO5459072, a low water‐soluble drug exhibiting complex food–drug interactions
por: Kratochwil, Nicole A., et al.
Publicado: (2021) -
Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome
por: Hargreaves, Patrick, et al.
Publicado: (2019) -
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers
por: Grippo, Joseph F., et al.
Publicado: (2021) -
Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib
por: Black, Donald M., et al.
Publicado: (2018) -
From ZeRO to HeRO: Saving lives one HeRO at a time
por: Ratcliff, Dr. Charlotte, et al.
Publicado: (2016)